PR Newswire
STOCKHOLM , Jan. 7, 2024 /PRNewswire/ -- Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) ("Calliditas") today announced that management will present at and participate in the 42nd Annual J.P. Morgan Healthcare Conference, which is taking place January 8-11, 2024 , in San Francisco, California . Calliditas will present an update on the company at 7:30 am PT on Tuesday 9th January.
For further information, please contact :
Åsa Hillsten, Head of IR & Sustainability, Calliditas
Tel.: +46 76 403 35 43, Email: asa.hillsten@calliditas.com
The information was sent for publication, through the agency of the contact person set out above, on January 7, 2024 at 3:00 p.m. CET .
About Calliditas
Calliditas Therapeutics is a biopharma company headquartered in Stockholm, Sweden , focused on identifying, developing, and commercializing novel treatments in orphan indications with significant unmet medical needs. Calliditas' common shares are listed on Nasdaq Stockholm (ticker: CALTX) and its American Depositary Shares are listed on the Nasdaq Global Select Market (ticker: CALT). Visit Calliditas.com for further information.
The following files are available for download:
JPM ENG |
SOURCE Calliditas Therapeutics